Disease-specific vaccines
- Enteric vaccines e.g. Cholera, Typhoid and Rotavirus
- Mosquito-borne viruses e.g. Dengue, Japanese encephalitis, Zika, Malaria and Chikungunya
- Respiratory viruses e.g. Influenza, Respiratory Syncitial virus
- Polio
- Measles, Mumps and Rubella
- Hepatitic viruses
- COVID-19
Evidenced-based introduction of new vaccines
- New vaccine introduction process
- Health economics of vaccines
- Programmatic issues and barriers to immunization
Monitoring and surveillance
- Disease surveillance
- Health Information Systems and Immunization Registries
- Meeting and monitoring vaccination coverage targets
- Vaccine safety monitoring and vaccine pharmacovigilance
Targeted vaccination strategies
- Pregnant mothers
- Adolescents
- Infancy and childhood
- Elderly
- School-based programs
Vaccine implementation
- Advocacy
- Communications and social mobilization
- Implementation of the Global Vaccine Action Plan
- Immunization legislation and insurance
Vaccines in specific settings
- Travel vaccines
- Vaccination in conflict zones and disaster areas
- Vaccines for special groups
- Vaccines for COVID-19
Vaccines in development
- New vaccine pipeline
- New and underused vaccines